IL1B and colitis: Antioxidant, anti-inflammatory, and immunomodulatory activities.In vivo model: decreases DSS-induced colitis and regulates autophagy. It is associated with the inhibition of ROS production (intracellular/extracellular), TNF-α, IL-1β, and IL-6.It also inhibits cell proliferation.